• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Increased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina.白细胞 Rac 相关卷曲螺旋蛋白激酶活性升高预测冠状动脉痉挛性心绞痛的存在和严重程度。
Atherosclerosis. 2012 Apr;221(2):521-6. doi: 10.1016/j.atherosclerosis.2012.01.001. Epub 2012 Jan 12.
2
Increased Rho kinase activity in a Taiwanese population with metabolic syndrome.台湾代谢综合征人群中Rho激酶活性增加。
J Am Coll Cardiol. 2007 Apr 17;49(15):1619-1624. doi: 10.1016/j.jacc.2006.12.043. Epub 2007 Apr 2.
3
Enhanced Rho-kinase activity in patients with vasospastic angina after the Great East Japan Earthquake.大震灾之后,伴有血管痉挛性心绞痛患者 Rho 激酶活性增强。
Circ J. 2012;76(12):2892-4. doi: 10.1253/circj.cj-12-1238. Epub 2012 Nov 3.
4
A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome.Rho 激酶活性增加和 N 末端 pro-B 型利钠肽联合预测急性冠状动脉综合征患者心血管预后不良。
Int J Cardiol. 2013 Sep 10;167(6):2813-9. doi: 10.1016/j.ijcard.2012.07.007. Epub 2012 Aug 24.
5
Elevated rho-kinase activity as a marker indicating atherosclerosis and inflammation burden in polyvascular disease patients with concomitant coronary and peripheral arterial disease. Rho-kinase 活性升高可作为伴有冠状动脉和外周动脉疾病的多血管疾病患者动脉粥样硬化和炎症负担的标志物。
Clin Cardiol. 2013 Jun;36(6):347-51. doi: 10.1002/clc.22118. Epub 2013 Mar 28.
6
Prognostic impacts of Rho-kinase activity in circulating leucocytes in patients with vasospastic angina.在伴有血管痉挛性心绞痛的患者中,循环白细胞中 Rho 激酶活性的预后影响。
Eur Heart J. 2018 Mar 14;39(11):952-959. doi: 10.1093/eurheartj/ehx657.
7
Enhanced Rho-kinase activity in circulating neutrophils of patients with vasospastic angina: a possible biomarker for diagnosis and disease activity assessment.痉挛性心绞痛患者循环中性粒细胞中 Rho 激酶活性增强:一种可能的诊断和疾病活动评估的生物标志物。
J Am Coll Cardiol. 2011 Sep 13;58(12):1231-7. doi: 10.1016/j.jacc.2011.05.046.
8
Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease.抗痉挛药物(钙拮抗剂和/或硝酸异山梨酯)对无血流动力学显著意义的冠状动脉疾病的冠状动脉痉挛性心绞痛患者高敏C反应蛋白的影响。
Am J Cardiol. 2005 Jan 1;95(1):84-7. doi: 10.1016/j.amjcard.2004.08.064.
9
Coronary Vasospasm Abutting the Stent: A Rare Though Important Cause of Recurrent Angina.冠状动脉痉挛紧邻支架:复发性心绞痛的一个罕见但重要的病因
J Invasive Cardiol. 2018 Jun;30(6):E46-E47.
10
Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease.无显著固定性冠状动脉疾病的冠状动脉痉挛患者与有显著固定性冠状动脉疾病的稳定型心绞痛患者及急性冠状动脉综合征患者血清炎症标志物水平的比较。
Am J Cardiol. 2006 May 15;97(10):1429-34. doi: 10.1016/j.amjcard.2005.12.035. Epub 2006 Mar 27.

引用本文的文献

1
Coronary Spasm Testing with Acetylcholine: A Powerful Tool for a Personalized Therapy of Coronary Vasomotor Disorders.乙酰胆碱激发试验:冠状动脉痉挛检测——冠状动脉血管舒缩障碍个体化治疗的有力工具
Life (Basel). 2024 Feb 22;14(3):292. doi: 10.3390/life14030292.
2
Elevated Leukocyte Count and Platelet-Derived Thrombogenicity Measured Using the Total Thrombus-Formation Analysis System in Patients with ST-Segment Elevation Myocardial Infarction.ST 段抬高型心肌梗死患者采用全血栓形成分析系统检测白细胞计数和血小板衍生的血栓形成能力升高。
J Atheroscler Thromb. 2024 Sep 1;31(9):1277-1292. doi: 10.5551/jat.64395. Epub 2024 Mar 6.
3
Relationship between Inflammation and Vasospastic Angina.炎症与血管痉挛性心绞痛的关系。
Medicina (Kaunas). 2023 Feb 9;59(2):318. doi: 10.3390/medicina59020318.
4
Apolipoprotein (a)/Lipoprotein(a)-Induced Oxidative-Inflammatory 7-nAChR/p38 MAPK/IL-6/RhoA-GTP Signaling Axis and M1 Macrophage Polarization Modulate Inflammation-Associated Development of Coronary Artery Spasm.载脂蛋白(a)/脂蛋白(a)诱导的氧化炎症 7 型烟碱型乙酰胆碱受体/p38MAPK/IL-6/RhoA-GTP 信号轴和 M1 巨噬细胞极化调节炎症相关的冠状动脉痉挛发展。
Oxid Med Cell Longev. 2022 Jan 19;2022:9964689. doi: 10.1155/2022/9964689. eCollection 2022.
5
Garcinol Attenuates Lipoprotein(a)-Induced Oxidative Stress and Inflammatory Cytokine Production in Ventricular Cardiomyocyte through α7-Nicotinic Acetylcholine Receptor-Mediated Inhibition of the p38 MAPK and NF-κB Signaling Pathways.藤黄脂素通过α7-烟碱型乙酰胆碱受体介导的对p38丝裂原活化蛋白激酶和核因子κB信号通路的抑制作用,减轻脂蛋白(a)诱导的心室心肌细胞氧化应激和炎性细胞因子生成。
Antioxidants (Basel). 2021 Mar 16;10(3):461. doi: 10.3390/antiox10030461.
6
Coronary artery lumen complexity as a new marker for refractory symptoms in patients with vasospastic angina.冠状动脉管腔复杂性作为血管痉挛性心绞痛患者难治性症状的新标志物。
Sci Rep. 2021 Jan 8;11(1):13. doi: 10.1038/s41598-020-79669-1.
7
Coronary Artery Spasm: New Insights.冠状动脉痉挛:新的认识。
J Interv Cardiol. 2020 May 14;2020:5894586. doi: 10.1155/2020/5894586. eCollection 2020.
8
The Biochemical Markers Associated with the Occurrence of Coronary Spasm.与冠状动脉痉挛发生相关的生化标志物。
Biomed Res Int. 2019 Sep 17;2019:4834202. doi: 10.1155/2019/4834202. eCollection 2019.
9
Association of moderate aerobic exercise and rho-associated kinase 2 concentration in subjects with dyslipidemia.血脂异常患者中适度有氧运动与Rho相关激酶2浓度的关联。
Arch Med Sci. 2017 Jun;13(4):807-812. doi: 10.5114/aoms.2017.68142. Epub 2017 Jun 12.
10
Pleiotropic Effects of Statins on the Cardiovascular System.他汀类药物对心血管系统的多效性作用
Circ Res. 2017 Jan 6;120(1):229-243. doi: 10.1161/CIRCRESAHA.116.308537.

本文引用的文献

1
Rho-kinase: important new therapeutic target in cardiovascular diseases.Rho-kinase:心血管疾病治疗的新靶点。
Am J Physiol Heart Circ Physiol. 2011 Aug;301(2):H287-96. doi: 10.1152/ajpheart.00327.2011. Epub 2011 May 27.
2
Current advances in the understanding of coronary vasospasm.冠状动脉痉挛认识的当前进展
World J Cardiol. 2010 Feb 26;2(2):34-42. doi: 10.4330/wjc.v2.i2.34.
3
Calcium channel blocker and Rho-associated kinase activity in patients with hypertension.高血压患者的钙通道阻滞剂和 Rho 相关激酶活性。
J Hypertens. 2011 Feb;29(2):373-9. doi: 10.1097/HJH.0b013e328340902d.
4
Interactions among gender, age, hypertension and C-reactive protein in coronary vasospasm.性别、年龄、高血压与 C 反应蛋白在冠状动脉痉挛中的相互作用。
Eur J Clin Invest. 2010 Dec;40(12):1094-103. doi: 10.1111/j.1365-2362.2010.02360.x. Epub 2010 Aug 16.
5
Statins inhibit Rho kinase activity in patients with atherosclerosis.他汀类药物可抑制动脉粥样硬化患者的Rho激酶活性。
Atherosclerosis. 2009 Aug;205(2):517-21. doi: 10.1016/j.atherosclerosis.2008.12.023. Epub 2008 Dec 24.
6
Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation.他汀类药物在人体中的多效性证据:他汀类药物与依折麦布对含Rho相关卷曲螺旋蛋白激酶活性、内皮功能和炎症的不同影响
Circulation. 2009 Jan 6;119(1):131-8. doi: 10.1161/CIRCULATIONAHA.108.813311. Epub 2008 Dec 15.
7
Coronary artery spasm--clinical features, diagnosis, pathogenesis, and treatment.冠状动脉痉挛——临床特征、诊断、发病机制及治疗
J Cardiol. 2008 Feb;51(1):2-17. doi: 10.1016/j.jjcc.2008.01.001. Epub 2008 Feb 1.
8
ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury.ROCK1介导血管损伤后的白细胞募集和新生内膜形成。
J Clin Invest. 2008 May;118(5):1632-44. doi: 10.1172/JCI29226.
9
Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis.冠状动脉痉挛是细小病毒B19心肌炎患者胸痛的潜在病因。
Heart. 2008 Nov;94(11):1456-63. doi: 10.1136/hrt.2007.131383. Epub 2008 Jan 29.
10
Rho kinase (ROCK) inhibitors.Rho激酶(ROCK)抑制剂。
J Cardiovasc Pharmacol. 2007 Jul;50(1):17-24. doi: 10.1097/FJC.0b013e318070d1bd.

白细胞 Rac 相关卷曲螺旋蛋白激酶活性升高预测冠状动脉痉挛性心绞痛的存在和严重程度。

Increased leukocyte Rho-associated coiled-coil containing protein kinase activity predicts the presence and severity of coronary vasospastic angina.

机构信息

Department of Cardiology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Keelung, Taiwan.

出版信息

Atherosclerosis. 2012 Apr;221(2):521-6. doi: 10.1016/j.atherosclerosis.2012.01.001. Epub 2012 Jan 12.

DOI:10.1016/j.atherosclerosis.2012.01.001
PMID:22293227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3312984/
Abstract

OBJECTIVE

Although inhibition of Rho-associated coiled-coil containing protein kinase (ROCK) has been shown to prevent coronary vasospastic angina (CVA), direct evidence linking ROCK activity and CVA is lacking. Accordingly, we investigated whether ROCK activity is an independent marker for CVA and is altered after treatment with antispastic medications.

METHODS AND RESULTS

We prospectively studied 31 Taiwanese patients who were diagnosed with CVA and 33 control subjects. Subject demographics were recorded, and blood samples were obtained at baseline in all participants and in CVA patients after 3 months of antispastic treatment. Compared with control subjects, leukocyte ROCK activity was greater in CVA patients (136% versus 91%, P<0.001). A cutoff value for leukocyte ROCK activity of 104% predicted the presence of CVA with specificity and sensitivity rates of 88% and 84%, respectively. ROCK activity increased with the severity of CVA (P for trend<0.001). Following 3-month treatment of antispastic agents, leukocyte ROCK activity, high-sensitivity C-reactive protein, and interleukin-6 levels were reduced by 43%, 42% and 27%, respectively (P<0.05 for all).

CONCLUSIONS

Increased levels of leukocyte ROCK activity independently predicted the presence of CVA and correlated with CVA severity. Treatment with antispastic agents substantially reduced the level of leukocyte ROCK activity.

摘要

目的

尽管 Rho 相关卷曲螺旋蛋白激酶(ROCK)抑制已被证实可预防冠状动脉痉挛性心绞痛(CVA),但与 CVA 相关的 ROCK 活性的直接证据仍然缺乏。因此,我们研究了 ROCK 活性是否为 CVA 的独立标志物,以及在抗痉挛药物治疗后是否发生改变。

方法和结果

我们前瞻性研究了 31 例被诊断为 CVA 的台湾患者和 33 例对照者。记录了受试者的人口统计学数据,并在所有参与者和 CVA 患者接受 3 个月抗痉挛治疗后获得了基线时的血液样本。与对照组相比,CVA 患者的白细胞 ROCK 活性更高(136%比 91%,P<0.001)。白细胞 ROCK 活性的截断值为 104%,预测 CVA 的特异性和敏感性分别为 88%和 84%。ROCK 活性随 CVA 的严重程度而增加(趋势 P<0.001)。在接受抗痉挛药物治疗 3 个月后,白细胞 ROCK 活性、高敏 C 反应蛋白和白细胞介素-6 水平分别降低了 43%、42%和 27%(P<0.05)。

结论

白细胞 ROCK 活性升高可独立预测 CVA 的存在,并与 CVA 严重程度相关。抗痉挛药物治疗可显著降低白细胞 ROCK 活性。